Mayo Clinic Proceedings Home

42-Year-Old Man With Asthma Symptoms and Recurrent Bronchitis

      A 42-year-old man from southern Iowa presented to our institution for evaluation of symptoms of asthma and recurrent bronchitis. The patient’s body mass index was 17.0, and he had never smoked. Since high school, he had had a persistent, productive cough. Asthma had been diagnosed years previously, and over the years, multiple medications were prescribed including fluticasone/salmeterol HFA, montelukast, albuterol, other inhaled glucocorticoids, and ipratropium/albuterol nebulization. The medications were minimally effective at controlling respiratory symptoms.
      To read this article in full you will need to make a payment

      References

        • Burke W.
        • Aitken M.L.
        • Chen S.H.
        • Scott C.R.
        Variable severity of pulmonary disease in adults with identical cystic fibrosis mutations.
        Chest. 1992; 102: 506-509
        • Gan K.H.
        • Geus W.P.
        • Bakker W.
        • Lamers C.B.
        • Heijerman H.G.
        Genetic and clinical features of patients with cystic fibrosis diagnosed after the age of 16 years.
        Thorax. 1995; 50: 1301-1304
        • Modolell I.
        • Alvarez A.
        • Guarner L.
        • De Gracia J.
        • Malagelada J.R.
        Gastrointestinal, liver, and pancreatic involvement in adult patients with cystic fibrosis.
        Pancreas. 2001; 22: 395-399
        • Rodman D.M.
        • Polis J.M.
        • Heltshe S.L.
        • et al.
        Late diagnosis defines a unique population of long-term survivors of cystic fibrosis.
        Am J Respir Crit Care Med. 2005; 171: 621-626
        • Widerman E.
        • Millner L.
        • Sexauer W.
        • Fiel S.
        Health status and sociodemographic characteristics of adults receiving a cystic fibrosis diagnosis after age 18 years.
        Chest. 2000; 118: 427-433
        • Flume P.A.
        • Mogayzel Jr., P.J.
        • Robinson K.A.
        • et al.
        • Clinical Practice Guidelines for Pulmonary Therapies Committee
        Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations.
        Am J Respir Crit Care Med. 2009; 180: 802-808
        • Konstan M.W.
        • Byard P.J.
        • Hoppel C.L.
        • Davis P.B.
        Effect of high-dose ibuprofen in patients with cytstic fibrosis.
        N Engl J Med. 1995; 332: 848-854
        • Davis P.B.
        • Drumm M.
        • Konstan M.W.
        Cystic fibrosis.
        Am J Respir Crit Care Med. 1996; 154: 1229-1256
        • Farrell P.M.
        • Rosenstein B.J.
        • White T.B.
        • et al.
        Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report.
        J Pediatr. 2008; 153: S4-S14
        • Cystic Fibrosis Foundation Patient Registry
        Annual Data Report to the Center Directors.
        Cystic Fibrosis Foundation, Bethesda, MD2013
        • Gilljam M.
        • Ellis L.
        • Corey M.
        • Zielenski J.
        • Durie P.
        • Tullis D.E.
        Clinical manifestations of cystic fibrosis among patients with diagnosis in adulthood.
        Chest. 2004; 126: 1215-1224
        • O'Sullivan B.P.
        • Freedman S.D.
        Cystic fibrosis.
        Lancet. 2009; 373: 1891-1904
        • Borowitz D.
        • Parad R.B.
        • Sharp J.K.
        • et al.
        Cystic Fibrosis Foundation practice guidelines for the management of infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome during the first two years of life and beyond.
        J Pediatr. 2009; 155: S106-S116
        • Rowe S.M.
        • Clancy J.P.
        • Wilschanski M.
        Nasal potential difference measurements to assess CFTR ion channel activity.
        Methods Mol Biol. 2011; 741: 69-86
        • Groman J.D.
        • Karczeski B.
        • Sheridan M.
        • Robinson T.E.
        • Fallin M.D.
        • Cutting G.R.
        Phenotypic and genetic characterization of patients with features of “nonclassic” forms of cystic fibrosis.
        J Pediatr. 2005; 146: 675-680
      CORRECT ANSWERS: 1. a. 2. c. 3. d. 4. b. 5. e